市場調査レポート

商品コード

栄養補助食品CDMO市場- 成長、将来展望、競合分析、2023年～2031年

Nutraceuticals CDMO Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

出版日: 2023年07月05日
発行: Acute Market Reports
ページ情報: 英文 116 Pages
納期: 即日から翌営業日

価格

PDF (Single User License)

USD 4,500 651,915円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 6,500 941,655円

レポートPDFを10名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 9,000 1,303,830円

レポートPDFを企業内すべての方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.87円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

栄養補助食品CDMO（開発・製造受託機関）市場は、カスタマイズされた栄養補助食品に対する需要の増加と製造・開発プロセスのアウトソーシングにより、大きな成長を遂げています。この市場は、専門のCDMOが栄養補助食品企業に製剤開発、製造、包装、その他の関連サービスを提供するものです。栄養補助食品CDMOの市場収益は、拡大する栄養補助食品産業とコスト効率が高く効率的な製造ソリューションへのニーズによって、今後数年間で大きく成長すると予測されます。世界の栄養補助食品CDMO市場は、2023年から2031年の予測期間中にCAGR 7.9％で成長すると予測されます。この成長は、健康とウェルネスに対する消費者の意識の高まり、高齢化人口の増加、慢性疾患の有病率の増加などの要因によるものです。栄養補助食品企業は、その専門知識、能力、インフラを活用して製品開発を加速し、製造プロセスを合理化するために、CDMOへの依存度を高めています。

カスタマイズされた栄養補助食品への需要の高まり

栄養補助食品市場では、特定の消費者ニーズに対応するカスタマイズ製品の需要が急増しています。この原動力は、消費者の嗜好の変化、予防ヘルスケアへの関心の高まり、栄養補助食品が提供する潜在的な健康効果に対する意識の高まりなど、いくつかの要因に後押しされています。消費者は今日、独自の健康上の懸念や目標に対処する、個別化された的を絞ったソリューションを求めています。このようなカスタマイズの需要は、栄養補助食品企業がオーダーメイドの製品を提供する大きな機会を生み出します。CDMOは、このカスタマイズの需要に応える上で極めて重要な役割を果たしています。製剤開発の専門知識と最新の市場動向の理解により、CDMOは栄養補助食品企業が消費者の嗜好に沿った革新的な製品を生み出す手助けをすることができます。CDMOは、製品の有効性と訴求力を最適化する成分選択、剤形、送達システムに関する貴重な洞察を提供します。CDMOと協力することで、栄養補助食品企業は、ターゲットとする消費者の共感を得られる、ユニークで差別化された製品を開発することができます。

製造・開発プロセスのアウトソーシング

栄養補助食品CDMO市場における顕著な促進要因は、栄養補助食品企業による製造・開発プロセスのアウトソーシング動向の高まりです。この促進要因は主に、業務の合理化、コスト削減、マーケティング、販売、製品イノベーションなどのコアコンピタンスへの集中を望むことにあります。CDMOと提携することで、栄養補助食品企業は製造プロセスを最適化するためにCDMOの専門的能力とインフラを活用することができます。CDMOは、効率的な生産と高品質の基準を確保するための高度な設備、施設、技術的専門知識を有しています。CDMOは、製剤開発、原料調達、製造、包装、規制遵守を含むエンド・ツー・エンドのソリューションを提供しています。製造・開発プロセスをCDMOに委託することで、栄養補助食品企業は柔軟性と拡張性を得ることができます。変化する市場の需要に適応し、多額の設備投資をすることなく、生産量の変動を効率的に管理することができます。さらにCDMOは、スケールメリット、リソースの共有、サプライチェーン管理の専門知識を通じて、コスト効率を提供することができます。

規制遵守と品質保証

規制コンプライアンスと品質保証は、栄養補助食品CDMO市場の極めて重要な促進要因です。栄養補助食品業界は、製品の安全性、有効性、地域または国際規格への準拠を確保するために厳しい規制要件にさらされています。これらの規制を遵守することは、消費者の健康を守り、栄養補助食品企業の評判を維持するために不可欠です。CDMOは、栄養補助食品会社がこうした規制基準を満たすのをサポートする上で、重要な役割を果たしています。CDMOは規制状況に関する深い知識を有し、複雑な要件を通して企業を導くことができます。CDMOは適正製造規範（GMP）の遵守を促進し、製品が必要な仕様と基準を満たすことを保証する品質保証試験を実施します。CDMOと提携することで、栄養補助食品企業は規制の不適合に伴うリスクを軽減することができます。CDMOの品質管理、文書化、規制当局への提出に関する専門知識は、製品が規制ガイドラインに従って開発、製造、流通されることを保証します。この原動力となっているのは、消費者の安全性への関心の高まり、進化する規制の枠組みを遵守する必要性、そしてコンプライアンス違反がもたらす潜在的な法的・金銭的影響です。

規制遵守の課題

市場情勢における潜在的な抑制要因の一つは、複雑で変化し続ける規制状況です。栄養補助食品業界は、製品の安全性、有効性、コンプライアンスを確保するために、規制当局から様々な規制やガイドラインを課されています。これらの規制要件を満たすことは、栄養補助食品企業にとってもCDMOにとっても難しい課題です。栄養補助食品は、消費者の安全性と製品の品質を確保するために、規制当局の厳しい監視下に置かれています。適正製造基準（GMP）、表示要件、製品表示などの規制の遵守は、CDMOにとって厳しいものです。多様な地域的または国際的な規制を遵守する必要性は、一貫性と効率性の点で課題となりうる。栄養補助食品の規制状況は絶えず進化しています。新しい規制、ガイドライン、表示要件が導入され、既存の規制が改定されることもあります。このような変化に対応し、コンプライアンスを確保することは、CDMOにとって時間とリソースを要することであり、業務やタイムラインに影響を与える可能性があります。栄養補助食品業界はさまざまな地域や国で事業を展開しており、それぞれが独自の規制枠組みを持っています。世界にサービスを提供するCDMOは、市場ごとに大きく異なる多数の規制要件を通過する必要があります。このような差異を遵守することは複雑さを増し、CDMOの負担を増大させる。栄養補助食品CDMO市場では、規制遵守の課題が抑制要因になる可能性がある一方で、こうした課題はCDMOにとって、規制に関する専門知識を提供し、顧客のコンプライアンスを確保することで差別化を図る機会にもなり得ることに留意する必要があります。

錠剤とカプセル：栄養補助食品デリバリーの柱

栄養補助食品CDMO市場は、錠剤・カプセル剤、粉末剤、ソフトジェル剤、その他の剤形別に区分されます。それぞれの剤形には独自の特徴と利点があり、消費者の嗜好や要求の違いに対応しています。錠剤とカプセルは、栄養補助食品業界で最も一般的な剤形の一つです。これらの剤形は、利便性、正確な服用、摂取のしやすさを提供します。これらの剤形は親しみやすく、日常生活に取り入れやすいため、消費者の間で人気があります。栄養補助食品CDMO市場では、錠剤とカプセルの売上高が大きな割合を占めています。錠剤とカプセルは広く使用されており、従来の固形剤形に対する消費者の嗜好から、今後も需要が続くと予想されます。その他のカテゴリーには、グミ、液体、スプレー、舌下製剤など、栄養補助食品CDMO市場における様々な革新的な新しい剤形が含まれます。これらの剤形はユニークな送達メカニズムと消費者体験を提供します。その他のセグメントはニッチ製品を特徴としており、斬新で利便性の高い剤形に対する消費者の需要によって顕著な成長が見込まれます。

製造と包装：栄養補助食品CDMO市場をリード

製造・包装サービスには、規模に応じた栄養補助食品の製造と包装が含まれます。これには、ブレンド、カプセル化、打錠、ラベリング、包装などのプロセスが含まれます。これらのサービスは、効率的でコンプライアンスに準拠した製造オペレーションを確保するために極めて重要です。製造・包装サービスは、信頼性の高い高品質の製造能力に対する需要から、大きな収益割合を占めると予想されています。栄養補助食品CDMO市場における規制コンプライアンスサービスは、市場参入と消費者の信頼を確保する上で重要な役割を果たすため、比較的高いCAGRが見込まれています。これらのサービスは、栄養補助食品製品が規制当局によって設定された厳しい要件や基準を満たす上で重要な役割を果たしています。これらのサービスには、複雑な規制の枠組みの調整、必要な認証の取得、監査の実施、製品の安全性とコンプライアンスの確保などが含まれます。栄養補助食品業界に対する規制当局の監視の目はますます厳しくなっており、消費者の安全性と製品の品質に対する関心の高まりと相まって、強固な規制コンプライアンス・サービスに対する需要が高まっています。規制状況が進化を続け、より厳しくなるにつれ、栄養補助食品企業は、こうした複雑な状況を効果的に乗り切るために、規制コンプライアンスを専門とするCDMOに信頼を寄せています。

北米：収益と市場でのプレゼンスでリード

北米は栄養補助食品CDMO市場において大きな収益シェアを占めており、その強力な市場プレゼンス、高度な製造能力、明確に定義された規制の枠組みがその原動力となっています。この強い市場地位は、予防ヘルスケアへの関心の高まり、健康志向の高まり、健康志向のライフスタイルの採用などの要因によって、栄養補助食品や機能性食品に対する消費者の需要が増加していることに起因しています。アジア太平洋地域は、栄養補助食品の需要を促進する様々な要因に後押しされ、同市場においてダイナミックかつ高成長の地域となっています。この地域は人口が多く、可処分所得が増加し、ライフスタイルが変化し、中間層が増加しているため、栄養補助食品にとって肥沃な市場環境が形成されています。中国、日本、インドといった国々は、アジア太平洋地域の市場成長を牽引する上で極めて重要な役割を果たしています。膨大な人口を抱える中国は、増大する消費者需要に対応する栄養補助食品CDMOにとって大きなチャンスです。同国では中間層が増加し、健康とウェルネスへの関心が高まっているため、栄養補助食品や機能性食品の需要が急増しています。同様に日本も、高齢化社会と予防医療を重視する文化に後押しされ、栄養補助食品市場が確立しています。中間層が拡大し、健康意識が高まっているインドも、この地域の市場成長に大きく貢献しています。

競合情勢

市場概要
栄養補助食品CDMO市場：剤形別 2021-2031
栄養補助食品CDMO市場：サービス別 2021-2031
栄養補助食品CDMO市場：企業規模別 2021-2031
栄養補助食品CDMO市場：地域別 2021-2031
- 英国と欧州連合
  - 英国
  - ドイツ
  - スペイン
  - イタリア
  - フランス
  - その他欧州地域

第10章アジア太平洋の栄養補助食品CDMO市場 2021-2031

市場概要
栄養補助食品CDMO市場：剤形別 2021-2031
栄養補助食品CDMO市場：サービス別 2021-2031
栄養補助食品CDMO市場：企業規模別 2021-2031
栄養補助食品CDMO市場：地域別 2021-2031
- アジア太平洋
  - 中国
  - 日本
  - インド
  - オーストラリア
  - 韓国
  - その他アジア太平洋地域

第11章ラテンアメリカの栄養補助食品CDMO市場 2021-2031

市場概要
栄養補助食品CDMO市場：剤形別 2021-2031
栄養補助食品CDMO市場：サービス別 2021-2031
栄養補助食品CDMO市場：企業規模別 2021-2031
栄養補助食品CDMO市場：地域別 2021-2031
- ラテンアメリカ
  - ブラジル
  - メキシコ
  - その他ラテンアメリカ地域

第12章中東・アフリカの栄養補助食品CDMO市場 2021-2031

市場概要
栄養補助食品CDMO市場：剤形別 2021-2031
栄養補助食品CDMO市場：サービス別 2021-2031
栄養補助食品CDMO市場：企業規模別 2021-2031
栄養補助食品CDMO市場：地域別 2021-2031
- 中東・アフリカ
  - GCC
  - アフリカ
  - その他中東・アフリカ地域

第13章企業プロファイル

Catalent Lonza Group
Royal DSM
BASF
Kerry Group
Archer Daniels Midland
Glanbia
Capsugel
Aenova Group
NutraScience Labs
Nutragenesis
Pharmavite
SirioPharma
Balchem Corporation
SirioPharma International
その他の主要企業

図表

List of Tables

TABLE 1 Global Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 2 Global Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 3 Global Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 4 North America Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 5 North America Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 6 North America Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 7 U.S. Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 8 U.S. Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 9 U.S. Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 10 Canada Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 11 Canada Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 12 Canada Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 13 Rest of North America Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 14 Rest of North America Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 15 Rest of North America Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 16 UK and European Union Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 17 UK and European Union Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 18 UK and European Union Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 19 UK Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 20 UK Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 21 UK Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 22 Germany Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 23 Germany Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 24 Germany Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 25 Spain Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 26 Spain Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 27 Spain Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 28 Italy Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 29 Italy Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 30 Italy Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 31 France Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 32 France Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 33 France Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 34 Rest of Europe Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 35 Rest of Europe Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 36 Rest of Europe Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 37 Asia Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 38 Asia Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 39 Asia Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 40 China Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 41 China Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 42 China Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 43 Japan Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 44 Japan Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 45 Japan Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 46 India Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 47 India Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 48 India Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 49 Australia Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 50 Australia Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 51 Australia Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 52 South Korea Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 53 South Korea Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 54 South Korea Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 55 Latin America Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 56 Latin America Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 57 Latin America Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 58 Brazil Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 59 Brazil Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 60 Brazil Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 61 Mexico Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 62 Mexico Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 63 Mexico Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 64 Rest of Latin America Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 65 Rest of Latin America Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 66 Rest of Latin America Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 67 Middle East and Africa Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 68 Middle East and Africa Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 69 Middle East and Africa Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 70 GCC Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 71 GCC Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 72 GCC Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 73 Africa Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 74 Africa Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 75 Africa Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
TABLE 76 Rest of Middle East and Africa Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
TABLE 77 Rest of Middle East and Africa Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
TABLE 78 Rest of Middle East and Africa Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)

List of Figures

FIG. 1 Global Nutraceuticals CDMO Market: Market Coverage
FIG. 2 Research Methodology and Data Sources
FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
FIG. 4 Global Nutraceuticals CDMO Market: Quality Assurance
FIG. 5 Global Nutraceuticals CDMO Market, By Dosage Forms, 2022
FIG. 6 Global Nutraceuticals CDMO Market, By Services, 2022
FIG. 7 Global Nutraceuticals CDMO Market, By Company Size, 2022
FIG. 8 Global Nutraceuticals CDMO Market, By Geography, 2022
FIG. 9 Market Geographical Opportunity Matrix - Global Nutraceuticals CDMO Market, 2022

FIG. 10Market Positioning of Key Nutraceuticals CDMO Market Players, 2022

FIG. 11Global Nutraceuticals CDMO Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031

FIG. 12 Global Nutraceuticals CDMO Market, By Dosage Forms, 2022 Vs 2031, %
FIG. 13 Global Nutraceuticals CDMO Market, By Services, 2022 Vs 2031, %
FIG. 14 Global Nutraceuticals CDMO Market, By Company Size, 2022 Vs 2031, %
FIG. 15 U.S. Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
FIG. 16 Canada Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
FIG. 17 Rest of North America Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
FIG. 18 UK Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
FIG. 19 Germany Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
FIG. 20 Spain Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
FIG. 21 Italy Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
FIG. 22 France Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
FIG. 23 Rest of Europe Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
FIG. 24 China Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
FIG. 25 Japan Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
FIG. 26 India Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
FIG. 27 Australia Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
FIG. 28 South Korea Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
FIG. 29 Rest of Asia Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
FIG. 30 Brazil Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
FIG. 31 Mexico Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
FIG. 32 Rest of Latin America Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
FIG. 33 GCC Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
FIG. 34 Africa Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
FIG. 35 Rest of Middle East and Africa Nutraceuticals CDMO Market (US$ Million), 2021 - 2031

Product Code: 139651-07-23

The nutraceuticals CDMO (Contract Development and Manufacturing Organization) market is experiencing substantial growth due to increasing demand for customized nutraceutical products and the outsourcing of manufacturing and development processes. This market involves the provision of contract services by specialized CDMOs to nutraceutical companies for formulation development, manufacturing, packaging, and other related services. The market revenue for nutraceuticals CDMO is projected to grow significantly in the coming years, driven by the expanding nutraceutical industry and the need for cost-effective and efficient manufacturing solutions.The global nutraceuticals CDMO market is projected to grow at a CAGR of 7.9% during the forecast period of 2023 to 2031. This growth is attributed to factors such as the rising consumer awareness about health and wellness, the growing aging population, and the increasing prevalence of chronic diseases. Nutraceutical companies are increasingly relying on CDMOs to leverage their expertise, capabilities, and infrastructure to accelerate product development and streamline manufacturing processes.

Increasing Demand for Customized Nutraceutical Products

The nutraceuticals market is witnessing a surge in the demand for customized products that cater to specific consumer needs. This driver is propelled by several factors, including shifting consumer preferences, a growing focus on preventive healthcare, and the rising awareness of the potential health benefits offered by nutraceuticals. Consumers today seek personalized and targeted solutions that address their unique health concerns and goals. This demand for customization creates a significant opportunity for nutraceutical companies to offer tailored products. CDMOs play a pivotal role in meeting this demand for customization. With their expertise in formulation development and understanding of the latest market trends, CDMOs can help nutraceutical companies create innovative products that align with consumer preferences. They provide valuable insights into ingredient selection, dosage forms, and delivery systems that optimize the effectiveness and appeal of the products. By collaborating with CDMOs, nutraceutical companies can develop unique and differentiated offerings that resonate with their target consumers.

Outsourcing of Manufacturing and Development Processes

A prominent driver in the nutraceuticals CDMO market is the increasing trend of outsourcing manufacturing and development processes by nutraceutical companies. This driver is primarily motivated by the desire to streamline operations, reduce costs, and focus on core competencies such as marketing, sales, and product innovation. By partnering with CDMOs, nutraceutical companies can leverage their specialized capabilities and infrastructure to optimize manufacturing processes. CDMOs possess advanced equipment, facilities, and technical expertise to ensure efficient production and high-quality standards. They offer end-to-end solutions, including formulation development, ingredient sourcing, manufacturing, packaging, and regulatory compliance. Outsourcing manufacturing and development processes to CDMOs provides nutraceutical companies with flexibility and scalability. They can adapt to changing market demands and efficiently manage fluctuations in production volumes without incurring significant capital investments. Moreover, CDMOs can offer cost efficiencies through economies of scale, shared resources, and expertise in supply chain management.

Regulatory Compliance and Quality Assurance

Regulatory compliance and quality assurance are crucial drivers in the nutraceuticals CDMO market. The nutraceuticals industry is subject to stringent regulatory requirements to ensure product safety, efficacy, and compliance with regional or international standards. Compliance with these regulations is vital to protect consumer health and maintain the reputation of nutraceutical companies. CDMOs play a critical role in supporting nutraceutical companies in meeting these regulatory standards. They possess in-depth knowledge of the regulatory landscape and can guide companies through complex requirements. CDMOs facilitate adherence to Good Manufacturing Practices (GMP) and conduct quality assurance testing to ensure that products meet the necessary specifications and standards. By partnering with CDMOs, nutraceutical companies can mitigate the risks associated with regulatory non-compliance. CDMOs' expertise in quality control, documentation, and regulatory submissions ensures that products are developed, manufactured, and distributed in accordance with regulatory guidelines. This driver is driven by the increasing focus on consumer safety, the need to adhere to evolving regulatory frameworks, and the potential legal and financial consequences of non-compliance.

Regulatory Compliance Challenges

One of the potential restraints in the nutraceuticals CDMO market is the complex and ever-changing regulatory landscape. The nutraceutical industry is subject to various regulations and guidelines imposed by regulatory authorities to ensure product safety, efficacy, and compliance. Meeting these regulatory requirements can be challenging for both nutraceutical companies and CDMOs. Nutraceutical products are subject to rigorous regulatory scrutiny to ensure consumer safety and product quality. Compliance with regulations such as Good Manufacturing Practices (GMP), labeling requirements, and product claims can be demanding for CDMOs. The need to adhere to diverse regional or international regulations can pose challenges in terms of consistency and efficiency. The regulatory landscape for nutraceuticals is continuously evolving. New regulations, guidelines, and labeling requirements are introduced, and existing regulations may undergo revisions. Keeping up with these changes and ensuring compliance can be time-consuming and resource-intensive for CDMOs, potentially impacting their operations and timelines. The nutraceutical industry operates in different regions and countries, each with its own regulatory framework. CDMOs that offer services globally need to navigate through a multitude of regulatory requirements, which can differ significantly from one market to another. Adhering to these variations adds complexity and increases the burden on CDMOs. While regulatory compliance challenges can pose a restraint in the nutraceuticals CDMO market, it is important to note that these challenges can also present opportunities for CDMOs to differentiate themselves by providing regulatory expertise and ensuring compliance for their clients.

Tablets & Capsules: Pillars of Nutraceutical Delivery

The nutraceuticals CDMO market is segmented by dosage forms, including tablets & capsules, powder, softgel, and others. Each dosage form has its own characteristics and benefits, catering to different consumer preferences and requirements. Tablets and capsules are one of the most common dosage forms in the nutraceutical industry. They offer convenience, precise dosing, and ease of consumption. These dosage forms are popular among consumers due to their familiarity and ease of incorporating into daily routines. Tablets and capsules accounted for a significant revenue percentage in the nutraceuticals CDMO market. The demand for tablets and capsules is expected to continue due to their widespread use and consumer preference for traditional solid dosage forms. The others category includes various innovative and emerging dosage forms in the nutraceuticals CDMO market, such as gummies, liquids, sprays, and sublingual formulations. These dosage forms offer unique delivery mechanisms and consumer experiences. The others segment is characterized by niche products and is expected to witness notable growth, driven by consumer demand for novel and convenient dosage formats.

Manufacturing and Packaging: Leading the Nutraceuticals CDMO Market

Manufacturing and packaging services encompass the production and packaging of nutraceutical products at scale. This includes processes such as blending, encapsulation, tableting, labeling, and packaging. These services are crucial for ensuring efficient and compliant manufacturing operations. Manufacturing and packaging services are anticipated to hold a significant revenue percentage due to the demand for reliable and high-quality production capabilities. Regulatory compliance services in the nutraceuticals CDMO market are expected to witness a relatively high CAGR due to their critical role in ensuring market access and consumer trust. These services play a vital role in helping nutraceutical products meet the stringent requirements and standards set by regulatory authorities. They involve navigating complex regulatory frameworks, obtaining necessary certifications, conducting audits, and ensuring product safety and compliance. The increasing regulatory scrutiny on the nutraceutical industry, coupled with the rising focus on consumer safety and product quality, drives the demand for robust regulatory compliance services. As the regulatory landscape continues to evolve and become more stringent, nutraceutical companies rely on CDMOs specializing in regulatory compliance to navigate these complexities effectively.

North America: Leader in Revenue and Market Presence

North America holds a significant revenue share in the nutraceuticals CDMO market, driven by its robust market presence, advanced manufacturing capabilities, and well-defined regulatory framework. This strong market position can be attributed to the increasing consumer demand for dietary supplements and functional foods, driven by factors such as the growing focus on preventive healthcare, rising health consciousness, and the adoption of wellness-oriented lifestyles. Asia Pacific emerges as a dynamic and high-growth region in the nutraceuticals CDMO market, fueled by various factors that drive the demand for nutraceutical products. The region's large population base, rising disposable income, shifting lifestyles, and the growing middle class create a fertile market landscape for nutraceuticals. Countries like China, Japan, and India play a pivotal role in driving the market growth in the Asia Pacific region. With its massive population, China presents substantial opportunities for nutraceuticals CDMOs to cater to the increasing consumer demand. The rising middle class in the country, coupled with a growing focus on health and wellness, has led to a surge in demand for dietary supplements and functional foods. Similarly, Japan has a well-established nutraceutical market, driven by the aging population and the cultural emphasis on preventive healthcare. India, with its expanding middle class and rising health awareness, is also a key contributor to the region's market growth.

Competitive Landscape

The Nutraceuticals CDMO market features a competitive landscape with key players such as Catalent, Lonza Group, Royal DSM, BASF, Kerry Group, Archer Daniels Midland, Glanbia, Capsugel, Aenova Group, NutraScience Labs, Nutragenesis, Pharmavite, SirioPharma, Balchem Corporation, and SirioPharma International. These companies provide a wide range of services including formulation development, manufacturing, packaging, and quality control for nutraceutical products. The market's competitive trends are driven by factors such as innovation, technological advancements, geographic expansion, strategic partnerships, and acquisitions aimed at enhancing capabilities and expanding service offerings.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofNutraceuticals CDMO market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Nutraceuticals CDMO market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Dosage Forms

Tablets & Capsules
Powder
Softgel
Others

Services

Product Formulation and Development
Manufacturing and Packaging
Research and Development (R&D)
Regulatory Compliance
Others

Company Size

Small Companies
Mid-Sized Companies
Large Companies

Region Segment (2021-2031; US$ Million)

North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Nutraceuticals CDMO market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Nutraceuticals CDMO market?

Which is the largest regional market for Nutraceuticals CDMO market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Nutraceuticals CDMO market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Nutraceuticals CDMO market worldwide?

1. Preface

1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted

2. Executive Summary

2.1. Market Snapshot: Global Nutraceuticals CDMO Market
2.2. Global Nutraceuticals CDMO Market, By Dosage Forms, 2022 (US$ Million)
2.3. Global Nutraceuticals CDMO Market, By Services, 2022 (US$ Million)
2.4. Global Nutraceuticals CDMO Market, By Company Size, 2022 (US$ Million)
2.5. Global Nutraceuticals CDMO Market, By Geography, 2022 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2022

3. Nutraceuticals CDMO Market: Competitive Analysis

3.1. Market Positioning of Key Nutraceuticals CDMO Market Vendors
3.2. Strategies Adopted by Nutraceuticals CDMO Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031

4. Nutraceuticals CDMO Market: Macro Analysis & Market Dynamics

4.1. Introduction
4.2. Global Nutraceuticals CDMO Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis

5. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)

5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
- 5.3.1. Tablets & Capsules
- 5.3.2. Powder
- 5.3.3. Softgel
- 5.3.4. Others

6. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)

6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
- 6.3.1. Product Formulation and Development
- 6.3.2. Manufacturing and Packaging
- 6.3.3. Research and Development (R&D)
- 6.3.4. Regulatory Compliance
- 6.3.5. Others

7. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)

7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
- 7.3.1. Small Companies
- 7.3.2. Mid-Sized Companies
- 7.3.3. Large Companies

8. North America Nutraceuticals CDMO Market, 2021-2031, USD (Million)

8.1. Market Overview
8.2. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
8.3. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
8.4. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
8.5.Nutraceuticals CDMO Market: By Region, 2021-2031, USD (Million)
- 8.5.1.North America
  - 8.5.1.1. U.S.
    - 8.5.1.1.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 8.5.1.1.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 8.5.1.1.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  - 8.5.1.2. Canada
    - 8.5.1.2.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 8.5.1.2.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 8.5.1.2.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  - 8.5.1.3. Rest of North America
    - 8.5.1.3.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 8.5.1.3.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 8.5.1.3.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)

9. UK and European Union Nutraceuticals CDMO Market, 2021-2031, USD (Million)

9.1. Market Overview
9.2. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
9.3. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
9.4. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
9.5.Nutraceuticals CDMO Market: By Region, 2021-2031, USD (Million)
- 9.5.1.UK and European Union
  - 9.5.1.1. UK
    - 9.5.1.1.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 9.5.1.1.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 9.5.1.1.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  - 9.5.1.2. Germany
    - 9.5.1.2.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 9.5.1.2.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 9.5.1.2.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  - 9.5.1.3. Spain
    - 9.5.1.3.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 9.5.1.3.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 9.5.1.3.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  - 9.5.1.4. Italy
    - 9.5.1.4.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 9.5.1.4.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 9.5.1.4.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  - 9.5.1.5. France
    - 9.5.1.5.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 9.5.1.5.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 9.5.1.5.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  - 9.5.1.6. Rest of Europe
    - 9.5.1.6.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 9.5.1.6.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 9.5.1.6.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)

10. Asia Pacific Nutraceuticals CDMO Market, 2021-2031, USD (Million)

10.1. Market Overview
10.2. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
10.3. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
10.4. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
10.5.Nutraceuticals CDMO Market: By Region, 2021-2031, USD (Million)
- 10.5.1.Asia Pacific
  - 10.5.1.1. China
    - 10.5.1.1.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 10.5.1.1.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 10.5.1.1.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  - 10.5.1.2. Japan
    - 10.5.1.2.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 10.5.1.2.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 10.5.1.2.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  - 10.5.1.3. India
    - 10.5.1.3.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 10.5.1.3.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 10.5.1.3.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  - 10.5.1.4. Australia
    - 10.5.1.4.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 10.5.1.4.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 10.5.1.4.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  - 10.5.1.5. South Korea
    - 10.5.1.5.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 10.5.1.5.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 10.5.1.5.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  - 10.5.1.6. Rest of Asia Pacific
    - 10.5.1.6.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 10.5.1.6.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 10.5.1.6.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)

11. Latin America Nutraceuticals CDMO Market, 2021-2031, USD (Million)

11.1. Market Overview
11.2. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
11.3. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
11.4. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
11.5.Nutraceuticals CDMO Market: By Region, 2021-2031, USD (Million)
- 11.5.1.Latin America
  - 11.5.1.1. Brazil
    - 11.5.1.1.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 11.5.1.1.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 11.5.1.1.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  - 11.5.1.2. Mexico
    - 11.5.1.2.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 11.5.1.2.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 11.5.1.2.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  - 11.5.1.3. Rest of Latin America
    - 11.5.1.3.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 11.5.1.3.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 11.5.1.3.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)

12. Middle East and Africa Nutraceuticals CDMO Market, 2021-2031, USD (Million)

12.1. Market Overview
12.2. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
12.3. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
12.4. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
12.5.Nutraceuticals CDMO Market: By Region, 2021-2031, USD (Million)
- 12.5.1.Middle East and Africa
  - 12.5.1.1. GCC
    - 12.5.1.1.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 12.5.1.1.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 12.5.1.1.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  - 12.5.1.2. Africa
    - 12.5.1.2.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 12.5.1.2.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 12.5.1.2.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  - 12.5.1.3. Rest of Middle East and Africa
    - 12.5.1.3.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
    - 12.5.1.3.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
    - 12.5.1.3.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)

13. Company Profile

13.1. Catalent, Lonza Group
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Portfolio
- 13.1.4. Strategic Initiatives
13.2. Royal DSM
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Portfolio
- 13.2.4. Strategic Initiatives
13.3. BASF
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Portfolio
- 13.3.4. Strategic Initiatives
13.4. Kerry Group
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Portfolio
- 13.4.4. Strategic Initiatives
13.5. Archer Daniels Midland
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Portfolio
- 13.5.4. Strategic Initiatives
13.6. Glanbia
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Portfolio
- 13.6.4. Strategic Initiatives
13.7. Capsugel
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Portfolio
- 13.7.4. Strategic Initiatives
13.8. Aenova Group
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Portfolio
- 13.8.4. Strategic Initiatives
13.9. NutraScience Labs
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Portfolio
- 13.9.4. Strategic Initiatives
13.10. Nutragenesis
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Portfolio
- 13.10.4. Strategic Initiatives
13.11. Pharmavite
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Portfolio
- 13.11.4. Strategic Initiatives
13.12. SirioPharma
- 13.12.1. Company Overview
- 13.12.2. Financial Performance
- 13.12.3. Product Portfolio
- 13.12.4. Strategic Initiatives
13.13. Balchem Corporation
- 13.13.1. Company Overview
- 13.13.2. Financial Performance
- 13.13.3. Product Portfolio
- 13.13.4. Strategic Initiatives
13.14. SirioPharma International
- 13.14.1. Company Overview
- 13.14.2. Financial Performance
- 13.14.3. Product Portfolio
- 13.14.4. Strategic Initiatives
13.15. Other Notable Players
- 13.15.1. Company Overview
- 13.15.2. Financial Performance
- 13.15.3. Product Portfolio
- 13.15.4. Strategic Initiatives

栄養補助食品CDMO市場- 成長、将来展望、競合分析、2023年～2031年

Nutraceuticals CDMO Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

カスタマイズされた栄養補助食品への需要の高まり

製造・開発プロセスのアウトソーシング

規制遵守と品質保証

規制遵守の課題

錠剤とカプセル：栄養補助食品デリバリーの柱

製造と包装：栄養補助食品CDMO市場をリード

北米：収益と市場でのプレゼンスでリード

競合情勢

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 栄養補助食品CDMO市場：競合分析

第4章 栄養補助食品CDMO市場：マクロ分析と市場力学

第5章 栄養補助食品CDMO市場：剤形別 2021-2031

第6章 栄養補助食品CDMO市場：サービス別 2021-2031

第7章 栄養補助食品CDMO市場：企業規模別 2021-2031

第8章 北米の栄養補助食品CDMO市場 2021-2031

第9章 英国と欧州連合の栄養補助食品CDMO市場 2021-2031

第10章 アジア太平洋の栄養補助食品CDMO市場 2021-2031

第11章 ラテンアメリカの栄養補助食品CDMO市場 2021-2031

第12章 中東・アフリカの栄養補助食品CDMO市場 2021-2031

第13章 企業プロファイル